| Literature DB >> 27891588 |
Annemieke S Littooij1, Thomas C Kwee1, Goya Enríquez2, Jonathan I M L Verbeke3, Claudio Granata4, Auke Beishuizen5, Charlotte de Lange6, Floriana Zennaro7, Marrie C A Bruin8, Rutger A J Nievelstein1.
Abstract
Osteonecrosis is a well-recognized complication in patients treated with corticosteroids. The incidence of osteonecrosis in children treated for Hodgkin lymphoma is unknown because prospective whole-body magnetic resonance imaging (MRI) studies are lacking in this patient population. Paediatric patients with newly diagnosed Hodgkin lymphoma who were treated according to a uniform paediatric Hodgkin protocol were eligible for inclusion in this prospective study. Whole-body MRI was performed in all 24 included patients (mean age 15·1 years, 12 girls) both before treatment and after 2 cycles of chemotherapy, and in 16 patients after completion of chemotherapy. Osteonecrosis was identified in 10 patients (41·7%, 95% confidence interval: 22·0-61·4%), with a total of 56 osteonecrotic sites. Osteonecrosis was detected in 8 patients after 2 cycles of OEPA (vincristine, etoposide, prednisone, doxorubicin), and in 2 additional patients after completion of chemotherapy. Epiphyseal involvement of long bones was seen in 4 of 10 children. None of the patients with osteonecrosis had any signs of bone collapse at the times of scanning. Whole-body MRI demonstrates osteonecrosis to be a common finding occurring during therapy response assessment of paediatric Hodgkin lymphoma. Detection of early epiphyseal osteonecrosis could allow for treatment before bone collapse and joint damage may occur.Entities:
Keywords: Osteonecrosis; late effects; paediatric Hodgkin Lymphoma; whole-body MRI
Mesh:
Substances:
Year: 2016 PMID: 27891588 DOI: 10.1111/bjh.14452
Source DB: PubMed Journal: Br J Haematol ISSN: 0007-1048 Impact factor: 6.998